About AccuMedical
AccuMedical is a Healthcare company based in Santa Ana (United States) founded in 2016. Neurovascular interventional devices for neurological disorders are developed. AccuMedical has raised $14.28 million across 3 funding rounds from investors including Taikang Insurance Group, Sequoia Capital and Huagai Capital. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its competitors include NovaVision, EnClear Therapies and Actipulse Neuroscience; 3 of its 3 listed competitors have raised funding.
Company details
AccuMedical was founded in 2016 and is headquartered in Santa Ana, United States. Neurovascular interventional devices are developed by the company for treating neurological disorders, including neurovascular malformation, cerebral aneurysm, ischemic stroke, and aneurysm conditions. Operations focus on device innovation within the medical technology sector, with a domain of accumedical.cn supporting global outreach. Various treatments are addressed through these specialized tools.
- Headquarters Santa Ana, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website accumedical.cn/en
- Total Equity Funding$14.28M (USD)
in 3 rounds
- InvestorsTaikang Insurance Group
& 5 more
Funding Insights of AccuMedical
AccuMedical has successfully raised a total of $14.28M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.28M
- Total Rounds 3
- Investors Count 6
All 3 funding rounds of AccuMedical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2020 | Series B | – | Sequoia Capital China, Huagai Capital | ||
| Jul 2020 | $14.28M | Series B | – | Sequoia Capital | |
| Aug 2019 | Series A | – | Proxima Ventures, BioTrack Capital | – |
6 investors in total: 6 institutional.
Investors in AccuMedical
AccuMedical has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Taikang Insurance Group, Sequoia Capital and Huagai Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investment firm focused on multiple sectors | huagaicapital.com | Dongguan, China | ||
| proximavc.com | ||||
| biotrackcapital.com | ||||
Sequoia Capital is engaged in venture capital investments. | 1972 | sequoiacap.com | ||
Venture capital firm focused on early-stage investments | sequoiacap.cn | Beijing, China | ||
Life insurance company | 1996 | taikang.com | Beijing, China |
Investor details for AccuMedical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of AccuMedical
3 dated milestones of AccuMedical across 4 years, from founding to its latest funding, stage changes and deals.
- Founded AccuMedical is founded.
- Funding First funding round.
- Funding Latest funding round, Series B,.
Competitors of AccuMedical
AccuMedical has 3 listed competitors in our database, 3 of them funded. They include NovaVision, EnClear Therapies and Actipulse Neuroscience.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| novavision.com | 2003 | Boca Raton, United States | $38M | Non-invasive devices are developed for vision restoration in stroke survivors. | ||
| encleartherapies.com | 2018 | Cambridge, United States | $12.72M | Developer of device-based therapies to treat neurodegenerative disorders | ||
| actipulseneuroscience.com | 2017 | Cambridge, United States | $125,000 | Non-invasive brain stimulation technology is developed for neurodegenerative disorders. |
Detailed competitors of AccuMedical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Neurology
3 companies that operate in the same segment as AccuMedical (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Accumedical
Complete news archive for AccuMedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AccuMedical
AccuMedical was founded in 2016 and raised its 1st funding round 3 years after it was founded.
AccuMedical is headquartered in Santa Ana, United States. It is registered at Santa Ana, California, United States.
AccuMedical is a funded company, having raised a total of $14.28M across 3 funding rounds to date.
AccuMedical was founded in 2016 and is headquartered in Santa Ana, United States. Neurovascular interventional devices are developed by the company for treating neurological disorders, including neurovascular malformation, cerebral aneurysm, ischemic stroke, and aneurysm conditions. Operations focus on device innovation within the medical technology sector, with a domain of accumedical.cn supporting global outreach. Various treatments are addressed through these specialized tools.
AccuMedical's top competitors include NovaVision, Actipulse Neuroscience and EnClear Therapies.
AccuMedical has 6 investors. Key investors include Taikang Insurance Group, Sequoia Capital, Huagai Capital, Proxima Ventures, and BioTrack Capital.